ATC code V08
ATC code V08 Contrast media is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup V08 is part of the anatomical group V Various.[4]
| ATC code V: Various |
|---|
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV08.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
V08A X-ray contrast media, iodinated
V08AA Water-soluble, nephrotropic, high osmolar X-ray contrast media
- V08AA01 Diatrizoic acid
- V08AA02 Metrizoic acid
- V08AA03 Iodamide
- V08AA04 Iotalamic acid
- V08AA05 Ioxitalamic acid
- V08AA06 Ioglicic acid
- V08AA07 Acetrizoic acid
- V08AA08 Iocarmic acid
- V08AA09 Methiodal
- V08AA10 Diodone
V08AB Water-soluble, nephrotropic, low osmolar X-ray contrast media
- V08AB01 Metrizamide
- V08AB02 Iohexol
- V08AB03 Ioxaglic acid
- V08AB04 Iopamidol
- V08AB05 Iopromide
- V08AB06 Iotrolan
- V08AB07 Ioversol
- V08AB08 Iopentol
- V08AB09 Iodixanol
- V08AB10 Iomeprol
- V08AB11 Iobitridol
- V08AB12 Ioxilan
V08AC Water-soluble, hepatotropic X-ray contrast media
- V08AC01 Iodoxamic acid
- V08AC02 Iotroxic acid
- V08AC03 Ioglycamic acid
- V08AC04 Adipiodone
- V08AC05 Iobenzamic acid
- V08AC06 Iopanoic acid
- V08AC07 Iocetamic acid
- V08AC08 Sodium iopodate
- V08AC09 Tyropanoic acid
- V08AC10 Calcium iopodate
V08AD Non-watersoluble X-ray contrast media
- V08AD01 Ethyl esters of iodised fatty acids
- V08AD02 Iopydol
- V08AD03 Propyliodone
- V08AD04 Iofendylate
V08B X-ray contrast media, non-iodinated
V08BA Barium sulfate containing X-ray contrast media
- V08BA01 Barium sulfate with suspending agents
- V08BA02 Barium sulfate without suspending agents
V08C Magnetic resonance imaging contrast media
V08CA Paramagnetic contrast media
- V08CA01 Gadopentetic acid
- V08CA02 Gadoteric acid
- V08CA03 Gadodiamide
- V08CA04 Gadoteridol
- V08CA05 Mangafodipir
- V08CA06 Gadoversetamide
- V08CA07 Ferric ammonium citrate
- V08CA08 Gadobenic acid
- V08CA09 Gadobutrol
- V08CA10 Gadoxetic acid
- V08CA11 Gadofosveset
- V08CA12 Gadopiclenol
V08CB Superparamagnetic contrast media
- V08CB01 Ferumoxsil
- V08CB02 Ferristene
- V08CB03 Iron oxide, nanoparticles
V08CX Other magnetic resonance imaging contrast media
- V08CX01 Perflubron
V08D Ultrasound contrast media
V08DA Ultrasound contrast media
- V08DA01 Perflutren, human albumin microspheres
- V08DA02 Microparticles of galactose
- V08DA03 Perflenapent
- V08DA04 Perflutren, phospholipid microspheres
- V08DA05 Sulfur hexafluoride, phospholipid microspheres
- V08DA06 Perflubutane, phospholipid microspheres
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code V08". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QV08". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.